Training primary health care professionals to prvide Buprenorphine and LAAM treatment

Substance Abuse

Volumn 23, Issue 4, 2002, Pages 245-254

  Lintzeris, Nicholas ^a   Dunlop, Adrian ^a   Muhleisen, Peter ^a   Ritter, Alison ^a  

^a TURNING POINT ALCOHOL AND DRUG CENTRE   (Australia)

Author keywords

Buprenorphine; General practice; LAAM; Pharmacists; Training

Indexed keywords

BUPRENORPHINE; DIAMORPHINE; LONG ACTING DRUG; METHADONE; OPIATE; OPIATE AGONIST; ACETYLMETHADOL; OPIATE RECEPTOR;

COMMUNITY CARE; DRUG ABUSE; DRUG DEPENDENCE; DRUG DEPENDENCE TREATMENT; EDUCATION PROGRAM; GENERAL PRACTICE; HEALTH CARE DELIVERY; HEROIN DEPENDENCE; HUMAN; METHADONE TREATMENT; PHARMACIST; PRIMARY HEALTH CARE; PRIMARY MEDICAL CARE; REVIEW; TRAINING; ARTICLE; DRUG POTENTIATION; EDUCATION; GENERAL PRACTITIONER; HEALTH CARE QUALITY; MEDICAL EDUCATION; METHODOLOGY; OPIATE ADDICTION; PROFESSIONAL COMPETENCE; STANDARD;

BUPRENORPHINE; EDUCATION, MEDICAL, CONTINUING; EDUCATION, PHARMACY, CONTINUING; HUMANS; METHADYL ACETATE; OPIOID-RELATED DISORDERS; PHARMACISTS; PHYSICIANS, FAMILY; PROFESSIONAL COMPETENCE; QUALITY OF HEALTH CARE; RECEPTORS, OPIOID;

EID: 0036885639     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897070209511497     Document Type: Article

References (24)

1. Ward J, Mattick RP, Hall W, eds: Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam: Harwood Academic Publishers; 1998
2. Commonwealth Department of Human Services and Health: Review of Methadone Treatment in Australia. Canberra: Commonwealth Department of Human Services and Health; 1995
3. Lintzeris N, Koutroulis G, Odgers P, Ezard N, Lanagan A, Muhleisen P, Stowe A: Report on the Evaluation of Community Methadone Services in Victoria. Fitzroy, Victoria: Turning Point Alcohol & Drug Centre; 1996
4. Drummer O, Opeskin K, Syrjanen M, Cordner S: Methadone toxicity causing death in ten subjects starting on a methadone maintenance program. Am J Forensic Med Pathol 1992; 13:346-350
5. Lintzeris N, Waters L: Teaching the fundamentals of methadone prescribing to General Practitioners In Victoria. In: National Methadone Conference, 1994, Sydney, Australia, 1994
6. Department of Health and Community Services: Victorian Methadone Program. Guidelines for Providers. Melbourne: Victorian Government Department of Health and Community Services; 1995
7. Kutin J, Lintzeris N: Introduction and background to the feasibility research. In: Ritter A, Kutin J, Lintzeris N, Bammer G, eds. Expanding Treatment Options for Heroin Dependence in Victoria: Buprenorphine, LAAM, Naltrexone and Slow-Release Oral Morphine. New Pharmacotherapies Project—Feasibility Phase. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre; 1997
8. Berbatis C, Svmderland V, Bulsara M, Lintzeris N: Tiends in licit opioid use in Australia, 1984-1998: Comparative analysis of international and jurisdictional data. Med J Aust 2000; 173:524-527
9. Ezard N, Lintzeris N, Odgers P, Koutroulis G, Muhleisen P: An evaluation of community methadone services in Victoria, Australia: Results of a client survey. Drug Alcohol Rev 1999; 18:417-423
10. Thomson N, Morgan K: Victorian Community Methadone Program: An Investigation Into Consumer Complaints and Grievances. Melbourne: VIVAIDS; 1999
11. Ling W, Rawson RA, Compton MA: Substitution pharmacotherapies for opioid addiction: From methadone to LAAM and buprenorphine. J Psychoactive Drugs 1994; 26:119-128
12. Mattick RP, Oliphant D, Ward J, Hall W: The effectiveness of other opioid replacement therapies: LAAM, heroin, buprenorphine, naltrexone and injectable maintenance. In: Ward JE, Mattick, Richard P, eds. Methadone Maintenance Treatment and Other Opioid Replacement Therapies. Amsterdam, Netherlands: Harwood Academic Publishers; 1998
13. Premier's Drug Advisory Council: Drugs and Our Community. Melbourne: Victorian Government; 1996
14. Auriacombe M, Franques P, Daulouede JP, Tignol J: The French experience: Results from extensive delimited research studies and nation-wide sample surveys. Res Clin Forums 1999; 21:9-16
15. Ritter A, Kutin J, Lintzeris N, Bammer G: Expanding Treatment Options for Heroin Dependence in Victoria: Buprenorphine, LAAM, Naltrexone and Slow-Release Oral Morphine. New Pharmacotherapies Project—Feasibility Phase. Fitzroy, Victoria: Turning Point Alcohol and Drug Centre; 1997
16. Allsop S, Bell J, Brough R, Dwyer P, Edmonds C, Lintzeris N, Mohindra V: Learning Objectives for Methadone Prescribers. Canberra: Australian Government Publishing Service; 1997
17. Lintzeris N, Clark N, Muhleisen P, Ritter A, Ali R, Bell J, Gowing L, Hawkin L, Henry Edwards SS, Mattick RP, Moheit B, Newton I, Quigley A, Whicker S, White J: National Clinical Guidelines and Procedures for the Use of Buprenorphine in the Treatment of Heroin Dependence. Canberra: Australian Government Publishing Service; 2001
18. Center for Substance Abuse Treatment: LAAM in the Treatment of Opiate Addiction. Rockville, MD: US. Department of Health and Human Services; 1995
19. Newble D, Dawson B, Dauphinee D, Page G, Macdonald M, Swanson D, Mulholland H, Thomson A, Van der Veuten: Guidelines for Assessing Clinical Competence. Teaching Learn Med 1994; 6:213-220
20. Page G, Bordage G, Allen Ti Developing Key-feature Problems and Examinations to Assess Clinical Decision-making Skills. Acad Med 1995; 70:194-201
21. Lintzeris N, Connolly K, Muhleisen P: Subutex Training Package. London: Wells Medical Group; 2001
22. Clark N, Ritter A, Lintzeris N, Kutin J, Bammer G: LAAM treatment in primary care settings: Results of a randomised controlled trial. Drug Alcohol Depend 2001; 63:S28
23. Ritter A, Lintzeris N, Clark N, Kutin J, Bammer G: A randomised trial of buprenorphine maintenance in primary care office-based settings: Clinical guidelines, training programs and efficacy. Drug Alcohol Depend 2001; 63:S131
24. Haines A, Freemantle N, Watt I, Lugon M: Increasing the effectiveness of clinical intervention. In: Miles A, Lugon M, eds. Effective Clinical Practice. Oxford: Blackwell Science; 1996